FGL1 and arthritic joint disease: Intraperitoneal administration of Fgl1 protein can significantly decrease inflammatory cytokine level in local paw tissue, prevent joint inflammation, cellular infiltration and bone deformation and attenuate collagen-induced arthritis progression in vivo.